Pharmaceutical & Biotechnology Outlooks by MP Advisors Now Available at MarketPublishers.com

09 Dec 2014 • by Natalie Aster

LONDON - Market Publishers Ltd announces that in-demand pharmaceutical and biotechnology outlooks elaborated by MP Advisors have been added to its catalogue.

Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma. In 2013, the pharmaceutical innovators in Japan have focused on orphan diseases, autoimmune and oncology sectors; this trend is set to prevail in the years to come. The topical report comprises a detailed examination of the pharmaceutical and biotechnology industry in Japan and focuses on the main market drivers, resistors and innovations. Major companies are profiled in the study, too. Besides, the report gives the pharma market outlook through 2018 …

Global Pharmaceutical and Biotechnology Outlook 2014 - India Pharma.  The Indian pharma companies lead the complex generics market in the US and the EU. Notably, the Indian factories have received less warning letters by the US FDA, which proves the high drugs quality. Such factors as the low cost production, government support and skilled workforce will encourage the further Indian biopharma market expansion. The study presents an all-round investigation of the Indian pharma industry, overviews the new drug developments and discusses the main producers performance …

Global Pharmaceutical & Biotechnology Outlook 2014: Mature Biotech. The positive growth in the biotech segment was observed during the last three years. The tendency is expected to continue in the future, given the development of innovative products, cost efficiency improvement and protection from generic threats. The comprehensive report offers unique data on the global biotech market performance, touches upon the major drivers and provides an in-depth analysis of the key biotech companies …

Global Pharmaceutical and Biotechnology Outlook 2014: Rising Stars. The new drugs development is encouraged by the rising need for innovative treatments for certain challenging diseases. In the future, the small research firms are expected to develop new drugs therapies and innovations. The in-demand report offers a detailed examination of the latest drug approvals, discusses the new product launches and reviews the potential milestones. Furthermore, it delves into the competitive environment and examines the pharma companies, including information on their pipelines, milestones and opportunities. The future prospects are highlighted …

More new market research studies by the publisher can be found at MP Advisors page.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected] 
MarketPublishers.com